EVG.L Share News (EVG)

EVG.L Information

There is currently no data for EVG

UK Shareholder Meetings Calendar - Next 7 Days

Thu, 09th Jul 2020 16:16

Friday 10 July

Urban Logistics REIT

Monday 13 July

Redcentric (re share issue)

Starcom

Fastforward Innovations

City of London Investment Group (re merger with Karpus Management)

Renalytix (re proposed Nasdaq dual listing)

Mitie (re rights issue)

Tuesday 14 July

easyJet (re fundraising)

Filta Group

Great Western Mining

Vistry Group (re bonus issue)

Itaconix (re fundraise)

Shires Income

QinetiQ

Wednesday 15 July

Europa Metals (re share consolidation)

Tullow Oil (re stake sale in Albert project)

Thalassa Holdings

Burberry Group

Biotech Growth Trust

Air Partner

Severn Trent

Danakali

Thursday 16 July

BT Group

DCC

Electrocomponents

Marshall Motors

Evgen Pharma

Renewi

Tiziana Life Sciences

Foresight Solar Fund

Trackwise Designs

Instem

Biffa

More News

8 Jun 2020 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

13 Feb 2020 16:17

Evgen Pharma, Rochester University To Advance SFX-01 For Trial

6 Feb 2020 13:45

Evgen Pharma Hails "Positive" Data From Breast Cancer Drug Research

17 Dec 2019 15:35

Evgen Pharma narrows loss, foresees 'clinical success'

(Sharecast News) - Evgen Pharma on Tuesday reported a narrowed interim loss and said it was confident of clinical success as it continues to develop its SFX-01 treatment.

17 Dec 2019 11:28

Evgen Pharma Outlook Confident Amid Clinical Success And Trimmed Loss

10 Dec 2019 15:59

UK Earnings, Trading Statements Calendar - Next 7 Days

5 Dec 2019 16:36

Evgen Pharma to advance SFX-01 trial with University of Dundee

(Sharecast News) - Clinical-stage drug development company Evgen Pharma has entered into a memorandum of understanding with the University of Dundee, it announced on Thursday, to advance SFX-01 towards a clinical trial in non-alcoholic steatohepatitis (NASH) and liver fibrosis.

5 Dec 2019 15:19

Evgen Pharma, University Of Dundee To Collaborate To Advance SFX-01 Trials

11 Nov 2019 12:23

UPDATE: Evgen Pharma "Unlikely" To Pursue Subarachnoid Development

11 Nov 2019 10:22

UK WINNERS & LOSERS SUMMARY: Greggs Surges 17% After Raising Guidance

11 Nov 2019 09:11

Evgen Pharma Shares Drop On "Disappointing" SFX-01 Trial Results

23 Sep 2019 13:09

Evgen Pharma "Delighted" With Extended Breast Cancer Treatment Results

23 Sep 2019 10:03

Evgen Pharma upbeat on latest news from SFX-01 studies

(Sharecast News) - Clinical stage drug development company Evgen Pharma announced on Monday that five patients who participated in the 'STEM' trial received 'SFX-01' treatment for more than one year, with two of those patients continuing to be treated with SFX-01.

28 Aug 2019 14:30

Evgen Pharma completes patient study visits in 'SAS' phase 2 trial

(Sharecast News) - Clinical stage drug development company Evgen Pharma announced on Wednesday that the last study visit for the last patient entered in the double-blind, placebo-controlled 'SAS' phase 2 clinical trial has taken place.

28 Aug 2019 12:06

Evgen Pharma Receives Last Patient For Stroke Treatment Drug Trial

(Alliance News) - Evgen Pharma PLC said Wednesday it has entered its last patient in the double-blind, placebo-controlled SAS Phase II clinical trial that is testing its SFX-01 product, aimed at a

Latest Share Chat

EVG.L Share News (EVG)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Shareholder Meetings Calendar - Next 7 Days

Login to your account

Quickpicks are a member only feature

Login to your account